Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. The Role of Cortisol in CNS Disease –11β-HSD1 Inhibition as a Potential New Therapeutic Strategy for Alzheimer’s Disease and Major Depressive Disorder 2026-10-16
  2. Newly diagnosed postoperative depression and incident dementia after major surgery: a Korean nationwide retrospective cohort study 2026-09-30
  3. Brain Iron Accumulation and Its Cognitive and Olfactory Correlates in Late-Life Depression 2026-09-10

Studies

139 studies carry this tag.

Date range

1972 to 2026

Top journals

  • Journal of affective disorders 6
  • The British journal of psychiatry : the journal of mental science 6
  • International journal of geriatric psychiatry 5
  • Journal of Alzheimer's disease : JAD 4
  • The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 4

94 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. The Role of Cortisol in CNS Disease –11β-HSD1 Inhibition as a Potential New Therapeutic Strategy for Alzheimer’s Disease and Major Depressive Disorder

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Preprints.org 2026-10-16 Risk factors

    Cortisol is primarily synthesized by the adrenal glands, but also within specific tissues via a distinct enzymatic pathway. 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) catalyses the synthesis of cortisol within cells to create local higher cortisol environments in those organs where it is highly expressed such as the liver and brain.

  2. Newly diagnosed postoperative depression and incident dementia after major surgery: a Korean nationwide retrospective cohort study

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-09-30 Risk factors

    Newly diagnosed postoperative depression was associated with increased dementia risk, particularly in patients aged < 65 years, supporting prospective evaluation as a potential marker of long-term cognitive risk.

  3. Brain Iron Accumulation and Its Cognitive and Olfactory Correlates in Late-Life Depression

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-09-10 Risk factors

    Late-life depression (LLD) is associated with cognitive impairment, olfactory dysfunction and dementia risk, while brain iron accumulation has been linked to depressive symptoms, cognitive impairment and Alzheimer’s disease progression.

  4. Long-term antidepressant use and outcomes in adults: A systematic review

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. PsyArXiv 2026-08-18 Brain scans and imaging

    Forty-eight studies, mostly of weak- or moderate-quality, met inclusion criteria.

  5. Point Prevalence of Common Mental Health Conditions in Nigeria: A Systematic Review and Meta-Analysis

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-08-13 How common it is

    These estimates are planning values for populations resembling the contributing studies, not national population rates.

  6. Distinguishing Apathy from Depression in Dementia: Implications for Diagnosis and Treatment

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Preprints.org 2026-08-03 Getting a diagnosis

    Apathy and depression are among the most common neuropsychiatric symptoms in dementia.

  7. Traumatic Brain Injury Increases Risk of Psychiatric Disorders Following Neurological Disease: Evidence from the UK Biobank Cohort

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-07-06 Disparities

    Lifetime TBI exposure is associated with increased likelihood and long-term risk of psychiatric disorders in individuals with dementia, stroke, and Parkinson’s disease, with mood disorders being the most consistent outcome across conditions.

  8. Social isolation and loneliness are increasingly recognized as detrimental risk factors for brain health.

  9. Pharmacotherapy for Depression in Long-Term Care: A Real-World EHR Study

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-03-16 Health systems and care delivery

    Overall, 81.7% of residents diagnosed with depression had ≥1 pharmacological depression treatment order.

  10. Reduced Plasma Aβ Peptides but Stable NfL and GFAP in Major Depressive Disorder

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. International journal of molecular sciences 2026-02-02 Biomarkers

    Major depressive disorder (MDD) has been associated with an increased risk of cognitive decline and neurodegenerative disorders like Alzheimer's disease (AD), prompting interest in peripheral biomarkers related to amyloid metabolism as well as neuroaxonal and astroglial injury.

  11. Neuromodulation and cognition in late-life depression

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2026-01-17 Risk factors

    Late-life depression (LLD) is associated with cognitive decline and increased risk of dementia.

  12. Lithium therapy and delayed progression of Alzheimer’s disease and related dementias in patients with bipolar disorder and mild neurocognitive disorders

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2026-01-13 Health systems and care delivery

    Recent mechanistic evidence identifies lithium deficiency as a driver of Alzheimer’s disease and related dementias (ADRD) pathogenesis.

  13. The effects of vortioxetine versus placebo on cognitive functioning in mild cognitive impairment: a placebo-controlled, randomized, double-blind study

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. medRxiv 2025-12-11 Clinical trials

    In a recent open-label, single-arm study, vortioxetine, an antidepressant, was associated with improved cognitive function in patients with MCI, however, no placebo-controlled studies have been conducted to support these findings.

  14. Treatment-resistant late-life depression prevalence and clinical/sociodemographic correlates: An electronic health records study

    ✓ Peer-reviewed alzhub usefulness score 75 out of 100. Journal of affective disorders 2025-04-01 Risk factors

    Of 8171 patients with late-life depression, 1443 (17.7 %) had TRLLD.

  15. Network models of late life depression symptoms and cognitive impairments across time

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Aging & mental health 2025-02-02 Risk factors

    Across 3544 participants, ≥65 years of age, with no diagnosed dementia-related disorders, the depression symptom everything was an effort showed high expected influence across all time points.

  16. Sex differences in the association between repetitive negative thinking and neurofilament light

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Npj mental health research 2024-11-11 Biomarkers

    Emerging evidence suggests that repetitive negative thinking (RNT; i.e., worry and ruminative brooding) is associated with biomarkers of Alzheimer's disease.

  17. Lithium: Fifteen Years Later

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Neuropsychobiology 2024-11-07 Drug development

    The 75th anniversary of introducing lithium into modern psychiatry is recognized, attested by the 1949 paper of John Cade.

  18. Trace Lithium for Suicide Prevention and Dementia Prevention: A Qualitative Review

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Pharmaceuticals (Basel, Switzerland) 2024-11-05 Drug development

    While most studies to date have been cross-sectional, limiting the establishment of causal relationships, the potential benefits of trace lithium for suicide prevention and dementia prevention are notable, especially in the absence of radical treatments for suicide and dementia.

  19. A Systematic Review of Antidepressants and Psychotherapy Commonly Used in the Treatment of Late Life Depression for Their Effects on Cognition

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2024-09-06 Risk factors

    Cognitive dysfunction is common in late life depression (LLD) and is a major risk factor for dementia.

  20. Lithium Exposure and Risk of Major Neurocognitive Disorders: A Systematic Review and Meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 89 out of 100. Journal of clinical psychopharmacology 2024-05-15 Drug development

    Eight studies with 377,060 subjects were included in the analysis.

  21. Depressive Symptoms Are Not Associated with Predementia Cerebrospinal Fluid Amyloid Pathology

    ✓ Peer-reviewed alzhub usefulness score 61 out of 100. Dementia and geriatric cognitive disorders extra 2024-05-10 Biomarkers

    Only the Aβ negative MCI group (MCI-Aβ-) was associated with depressive symptoms (odds ratio [OR] = 2.65, p = 0.005).

  22. Cerebrospinal fluid synaptic biomarker changes in bipolar disorder - A longitudinal case-control study

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of affective disorders 2024-05-07 Tau biomarkers

    The synaptic proteins revealed no statistically significant differences between BD and HC, neither at baseline, one-year follow-up, or in terms of changes from baseline to follow-up.

  23. Lithium Therapy's Potential to Lower Dementia Risk and the Prevalence of Alzheimer's Disease: A Meta-Analysis

    ✓ Peer-reviewed alzhub usefulness score 77 out of 100. European neurology 2024-04-24 Drug development

    A total of seven studies were included. The forest plot results showed that taking lithium therapy reduced the risk of AD (RR 0.59, 95% confidence interval [CI]: 0.44-0.78) and is also protective in reducing the risk of dementia (RR 0.66, 95% CI: 0.56-0.77).

  24. Preliminary evidence for preserved synaptic density in late-life depression

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Translational psychiatry 2024-03-14 Risk factors

    Late-life depression has been consistently associated with lower gray matter volume, the origin of which remains largely unexplained.

  25. Effect of computerized cognitive training on mood, cognition, and serum brain-derived neurotrophic factor level in late-life depression - a pilot randomized controlled trial

    ✓ Peer-reviewed alzhub usefulness score 77 out of 100. Frontiers in psychiatry 2024-01-17 Cognitive tests and assessment

    Our sample had a mean age of 66.8 (SD = 5.3) years, a mean HAM-D score of 19.4 (SD = 7.5), and a mean PHQ-9 score of 18.0 (SD = 6.3).

  26. The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Cells 2023-11-29 Risk factors

    Cortisol, a critical glucocorticoid hormone produced by the adrenal glands, plays a pivotal role in various physiological processes.

  27. Effects of lithium on serum Brain-Derived Neurotrophic Factor in Alzheimer's patients with agitation

    ✓ Peer-reviewed alzhub usefulness score 75 out of 100. International journal of geriatric psychiatry 2023-09 Drug development

    BDNF levels did not change significantly and were not associated with improvement in overall neuropsychiatric symptoms or in cognitive function.

  28. Treatment strategy for late-life depression

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. PCN reports : psychiatry and clinical neurosciences 2023-05-07 Risk factors

    With the unprecedented aging of the world's population, the number of elderly patients with depression is expected to increase.

  29. Late-life depression and multimorbidity trajectories: the role of symptom complexity and severity

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Age and ageing 2023-02-01 Risk factors

    in multi-adjusted models, relative to individuals without depression, those with major (β per year: 0.33, 95% confidence interval [CI]: 0.06-0.61) and subsyndromal depression (β per year: 0.21, 95%CI: 0.12-0.30) experienced an accelerated rate of somatic multimorbidity accumulation, whereas those with minor depression did not.

  30. Depressive and Biopsychosocial Frailty Phenotypes: Impact on Late-life Cognitive Disorders

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of Alzheimer's disease : JAD 2023 Risk factors

    In older age, frailty is a detrimental transitional status of the aging process featuring an increased susceptibility to stressors defined by a clinical reduction of homoeostatic reserves.

  31. Association between depression, gender and Alzheimer's neuropathology in older adults without dementia

    ✓ Peer-reviewed alzhub usefulness score 63 out of 100. International journal of geriatric psychiatry 2022-10 Risk factors

    This study included 407 participants (96 Thal, 405 Braak, and 406 CERAD).

  32. Locus coeruleus catecholamines link neuroticism and vulnerability to tau pathology in aging

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. NeuroImage 2022-09-30 Brain scans and imaging

    Higher neuroticism is a risk factor for Alzheimer's disease (AD), and is implicated in disordered stress responses.

  33. The role of cognitive and brain reserve in late-life depressive events: The Rotterdam Study

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Journal of affective disorders 2022-09-30 Risk factors

    Higher cognitive (HR: 0.91/SD, 95%CI: 0.84; 1.00) and brain reserve (HR: 0.88/SD, 95%CI: 0.77; 1.00) were associated with a lower risk of a depressive event after adjustment for baseline depressive symptoms.

  34. Olfactory loss is a predisposing factor for depression, while olfactory enrichment is an effective treatment for depression

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Frontiers in neuroscience 2022-09-28 Risk factors

    The loss of olfactory stimulation correlates well with at least 68 widely differing neurological disorders, including depression, and we raise the possibility that this relationship may be causal.

  35. Prevalence of Comorbid Dementia in Late-life Depression and Bipolar Disorder: A Retrospective Inpatient Study

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Journal of Alzheimer's disease reports 2022-09-24 Risk factors

    A total of 66 patients with MDD (n = 50) and BD (n = 16) were analyzed.

  36. Lithium in drinking water and Alzheimer's dementia: Epidemiological Findings from National Data Base of Japan

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Bipolar disorders 2022-09-13 Drug development

    The adjusted model showed a significant inverse association of lithium levels with female, but not with male, or total prevalence of AD.

  37. Clinical course and serum amyloid β levels in elderly patients with major depressive disorder

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of affective disorders 2022-08-03 Biomarkers

    The analysis revealed decreased Aβ42 levels and increased Aβ42/40 ratios in elderly patients with depression at admission compared with healthy subjects.

  38. Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. JAMA psychiatry 2022-07-01 Digital health tools

    In this cohort study of data from 8.38 million adults (4.18 million women, 4.20 million men; mean [SD] age 49.18 [18.45] years); 16 679 (0.02%) survived a hospital admission for SARI, and 32 525 (0.03%) survived a hospital admission for COVID-19.

  39. Vortioxetine Treatment for Depression in Alzheimer's Disease: A Randomized, Double-blind, Placebo-controlled Study

    ✓ Peer-reviewed alzhub usefulness score 54 out of 100. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology 2022-05-31 Clinical trials

    There was no statistically significant difference between the two groups in terms of depressive symptoms, cognitive functions, and ADL.

  40. Biological mechanisms and possible primary prevention of depression

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. World journal of psychiatry 2022-05-19 Prevention and risk

    Individuals with unipolar depressive disorder (UDD) are having an increased risk of death and development of dementia in later life.

  41. Antiviral, immunomodulatory, and neuroprotective effect of lithium

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of integrative neuroscience 2022-03-23 Drug development

    Currently, in psychiatry, lithium is a drug of choice as a mood stabilizer in the maintenance treatment of bipolar disorder for the prevention of manic and depressive recurrences.

  42. Disrupted olfactory functional connectivity in patients with late-life depression

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Journal of affective disorders 2022-03-13 Risk factors

    Compared with LLD patients without OI impairment and normal controls, LLD patients with OI impairment exhibited increased FC between the left orbital frontal cortex (OFC) and left calcarine gyrus, between the left OFC and right lingual gyrus, between the right OFC and right rectus gyrus, and decreased FC between the right piriform cortex and right superior parietal lobule.

  43. Brain pathology and cognitive scores prior to onset of late-life depression

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. International journal of geriatric psychiatry 2022-03 Risk factors

    In the incident depression group, there was a mild decline in cognitive scores from baseline to the visit before depression onset compared with the never-depressed group.

  44. Differences in Odor Identification in Early-Onset and Late-Onset Depression

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Brain sciences 2022-02-16 Risk factors

    LOD patients exhibited lower OI scores than EOD patients and normal controls (NCs).

  45. Cognitive functions in late-life depression

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Geriatrie et psychologie neuropsychiatrie du vieillissement 2022-01-21 Risk factors

    Cognitive disorders are frequently found during late-life depression (LLD).

  46. Depressive symptom profiles predict dementia onset and brain pathology in older persons. The AGES-Reykjavik study

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Neurobiology of aging 2021-11-27 Risk factors

    Late-life depression (LLD) increases risk for dementia and brain pathology, but possibly this is only true for one or more symptom profiles of LLD.

  47. Late-Life Depression, Cognitive Impairment, and Relationship with Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Dementia and geriatric cognitive disorders 2021-11-25 Risk factors

    This narrative review aimed to explore the existing knowledge in order to examine the multiple forms of late-life depression (LLD) within a non-neurodegenerative or a neurodegenerative context, in particular Alzheimer's disease (AD).

  48. Molecular Basis of Late-Life Depression

    ✓ Peer-reviewed alzhub usefulness score 73 out of 100. International journal of molecular sciences 2021-07-10 Risk factors

    Late-life depression (LLD), compared to depression at a young age, is more likely to have poor prognosis and high risk of progression to dementia.

  49. Dementia Syndrome of Depression: Diagnostic Challenges and Clinical Relevance

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Focus (American Psychiatric Publishing) 2021-07-09 Risk factors

    Late-life depression is frequently associated with cognitive impairment.

  50. Telomere shortening in late-life depression: A potential marker of depression severity

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Brain and behavior 2021-06-21 Risk factors

    TL was significantly shorter in the LLD compared with control participants (p = .039).

From across this tag

9 of the 139 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 9. The same 9 appear here every time.

All topic tags with their study counts